Jan B.
- Country
- Poland
- Department
- N/A
Research Overview
- 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
- A Pharmacokinetic and Safety Study of Bimekizumab via Different Routes of Administration in Adults with Chronic Cutaneous Inflammation
Data & Insights
Has run more than one trial at 342 of 637 partner sites.
Specializations
Psoriatic Conditions
The investigator specializes in treating moderate to severe plaque psoriasis and psoriatic arthritis, conducting extensive research into innovative therapeutic approaches.
- Plaque Psoriasis Management
- Special Area Psoriasis Treatment
- Biologic DMARD Therapies
Research involves evaluation of novel therapeutic agents for patients with varying degrees of psoriatic disease severity.
Rheumatological Disorders
Focused on advancing treatment options for rheumatoid arthritis and axial spondyloarthritis, with particular attention to autoimmune manifestations.
- Early-Stage Rheumatoid Arthritis
- Biosimilar Evaluation
- Anti-TNF Therapies
Investigates treatment responses in patients with varying levels of disease activity and prior treatment experience.
Osteoarthritis Research
Conducts research in knee osteoarthritis treatment, focusing on innovative approaches for managing chronic pain associated with the condition.
- Intra-articular Treatments
- Pain Management Strategies
- Long-term Pain Control
Evaluates novel therapeutic interventions for patients with moderate to severe osteoarthritic pain.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.